EXHIBIT 10.41
AGREEMENT dated as of March 17, 1997 between Xxxxx X. XxXxx ("XxXxx")
and EDITEK, Inc.
WHEREAS, EDITEK, is the owner of all the outstanding shares of MedTox
Laboratories, Inc., including the name of "MedTox"; and
WHEREAS, upon EDITEK's acquisition of MedTox Laboratories, Inc.'s
assets, XxXxx reserved rights to the name "MedTox" in certain events; and
WHEREAS, XxXxx is the Chairman and President of EDITEK and wishes to
assign all of his rights in the name of "MedTox" to EDITEK.
NOW THEREFORE, in consideration of the premises, the parties hereby
agree that XxXxx hereby unconditionally assigns to EDITEK whatever rights he has
to the name "MedTox." In furtherance of such assignment the Agreement dated as
of January 30, 1995, pursuant to which EDITEK assigned to XxXxx certain rights
to the name "MedTox", is hereby terminated.
IN WITNESS WHEREOF, the parties executed and delivered this Agreement.
EDITEK, INC.
______________________________ By: ______________________________
Xxxxx X. XxXxx Chief Executive Officer
